ONPH
Price:
$0.0001
Market Cap:
$2.74K
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.[Read more]
Industry
Biotechnology
IPO Date
1994-10-31
Stock Exchange
PNK
Ticker
ONPH
According to Oncology Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.74K. This represents a change of -99.92% compared to the average of 3.46M of the last 4 quarters.
The mean historical Enterprise Value of Oncology Pharma Inc. over the last ten years is 588.47M. The current 2.74K Enterprise Value has changed -99.95% with respect to the historical average. Over the past ten years (40 quarters), ONPH's Enterprise Value was at its highest in in the December 1999 quarter at 12.99B. The Enterprise Value was at its lowest in in the September 1999 quarter at -7300000.00.
Average
588.47M
Median
82.73M
Minimum
3.24M
Maximum
4.87B
Discovering the peaks and valleys of Oncology Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.42%
Maximum Annual Enterprise Value = 4.87B
Minimum Annual Increase = -1063017.88%
Minimum Annual Enterprise Value = 3.24M
Year | Enterprise Value | Change |
---|---|---|
2023 | 7.13M | -93.76% |
2022 | 114.31M | -61.55% |
2021 | 297.28M | 8.42% |
2020 | 3.49M | 7.58% |
2019 | 3.24M | -87.04% |
2004 | 25.02M | -51.09% |
2003 | 51.15M | -82.78% |
2002 | 297.07M | 38.22% |
2001 | 214.92M | -95.59% |
2000 | 4.87B | -1063017.88% |
The current Enterprise Value of Oncology Pharma Inc. (ONPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
139.57M
5-year avg
85.09M
10-year avg
588.47M
Oncology Pharma Inc.’s Enterprise Value is less than Regen BioPharma, Inc. (1.41M), less than Propanc Biopharma, Inc. (1.28M), less than Kaleido Biosciences, Inc. (4.26K), greater than RegeneRx Biopharmaceuticals, Inc. (2.10K), less than Regen BioPharma, Inc. (4.31M), less than Therapeutic Solutions International, Inc. (1.64B), less than Alpha Cognition Inc. (34.21M), less than HAVN Life Sciences Inc. (771.73K), less than Surrozen, Inc. (2.72M), less than Jasper Therapeutics, Inc. (258.87M), greater than Revelation Biosciences, Inc. (-3300245.00), less than Wesana Health Holdings Inc. (310.73K), less than Living Cell Technologies Limited (7.93M), less than MultiCell Technologies, Inc. (50.10K), less than Institute of Biomedical Research Corp. (23.43M), less than Health Sciences Group, Inc. (0), less than Mymetics Corporation (75.05M), less than Anebulo Pharmaceuticals, Inc. (35.94M), less than Aerovate Therapeutics, Inc. (46.38M), less than Acrivon Therapeutics, Inc. Common Stock (193.51M), less than Opthea Limited (300.06M), less than AN2 Therapeutics, Inc. (6.93M),
Company | Enterprise Value | Market cap |
---|---|---|
1.41M | $751.25K | |
1.28M | $180.86K | |
4.26K | $4.26K | |
2.10K | $2.10K | |
4.31M | $3.65M | |
1.64B | $3.07M | |
34.21M | $35.66M | |
771.73K | $550.05K | |
2.72M | $29.54M | |
258.87M | $337.91M | |
-3300245.00 | $3.19M | |
310.73K | $123.80K | |
7.93M | $7.17M | |
50.10K | $50.01K | |
23.43M | $23.03M | |
0 | $187.09K | |
75.05M | $152.00 | |
35.94M | $37.34M | |
46.38M | $76.95M | |
193.51M | $232.91M | |
300.06M | $509.36M | |
6.93M | $40.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncology Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncology Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oncology Pharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Oncology Pharma Inc. (ONPH)?
What is the 3-year average Enterprise Value for Oncology Pharma Inc. (ONPH)?
What is the 5-year average Enterprise Value for Oncology Pharma Inc. (ONPH)?
How does the current Enterprise Value for Oncology Pharma Inc. (ONPH) compare to its historical average?